×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
Compass Pathways
COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024,...
4 weeks ago
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
The Motley Fool
Compass Pathways Plc (CMPS -0.40%) Q1 2024 Earnings Call May 08, 2024, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers...
4 weeks ago
Quest Partners LLC Purchases New Shares in COMPASS Pathways plc (NASDAQ:CMPS)
Defense World
Read Quest Partners LLC Purchases New Shares in COMPASS Pathways plc (NASDAQ:CMPS) at Defense World.
3 days ago
Compass Pathways co-founders exit to pursue 'broader goals'
Green Market Report
Compass Pathways plc (Nasdaq: CMPS) saw its stock price slip more than 12% on news that that its co-founders resigned from the board of...
2 months ago
COMPASS Pathways Signals Confidence in Psychedelics with $285M in Funding
Behavioral Health Business
London-based COMPASS Pathways plc (Nasdaq: CMPS) has secured $285 million in private funding to advance the company toward offering...
9 months ago
COMPASS Pathways announces CFO transition
GlobeNewswire
LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS” or the “company”), a biotechnology company...
7 months ago
COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut? (CMPS)
Seeking Alpha
COMPASS has experienced delays with its COMP 005 clinical trial, but is confident with the unchanged timeline for COMP360.
1 month ago
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of ...
Compass Pathways
London, April 29, 2024. Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to...
1 month ago
Compass Pathways exec sells over $246k in company stock By Investing.com
Investing.com
COMPASS Pathways plc (NASDAQ:CMPS), a pharmaceutical company specializing in the development of psychiatric treatments, has reported a...
2 weeks ago
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
The Motley Fool
As a psychedelic therapy developer, Compass Pathways (CMPS -0.54%) is on the cutting edge of innovation in treating mood disorders.
2 weeks ago